Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Lead sponsor: Brigham and Women's Hospital to Brigham and Women's Hospital Show 6 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Jul 2027 to Sep 2026
    • Eligibility criteria expanded, about 7 words
    • Study description revised
    • Site details revised
    • Publications: details revised at 7 of 7 entries
  2. Re-verified, no change to tracked fieldsv14
  3. Minor Site contact updatedv13
  4. Notable Primary and study completion dates: Jul 2022 to Jul 2027v12
  5. Minor Site contact updatedv11
Show 9 earlier versionsHide 9 earlier versions
  1. Minor Site contact updatedv10
  2. Notable Primary and study completion dates: Jul 2018 to Jul 2022v9
  3. Minor Site contact updatedv8
  4. Re-verified, no change to tracked fieldsv7
  5. Minor Site contact updatedv6
  6. Re-verified, no change to tracked fieldsv5
  7. Minor Site contact updatedv4
  8. Minor Primary completion date: Jul 2018
    • Study completion date: Jul 2013 to Jul 2018
    • Study description revised
    • Site contact updated
    v3
  9. Notable Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to Brigham and Women's Hospital
    • Collaborators expanded, about 7 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Chronic obstructive pulmonary disease (COPD) is often caused by cigarette smoking, but genetic predisposition also influences COPD susceptibility. The purpose of this study is to identify genetic factors that predispose some individuals to develop COPD.
Trial Details
NCT Number NCT01177618
Lead Sponsor Brigham and Women's Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)
Chronic Obstructive Pulmonary Disease
Related terms Bronchitis, Chronic, Emphysema, Pulmonary Disease, Chronic Obstructive
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov